BackSyndax Pharmaceuticals Overview
Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Target Price

Where could SNDX trade next? Consensus target price: $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.54

Average Target Price

$37.5091.9% upside

6 analysts in the last 4 months

High: $46 | Low: $31

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-21UBSDavid Dai$3368.9% upsideOpen
2026-08-05H.C. Wainwright$3894.5% upsideOpen
2026-06-12GuggenheimBrad Canino$3158.6% upsideOpen
2026-06-03H.C. WainwrightAndres Maldonado$40104.7% upsideOpen
2026-05-04Stifel Nicolaus$46135.4% upsideOpen
2026-05-01Barclays$3789.4% upsideOpen
2026-02-27Stifel NicolausStephen Willey$45130.3% upsideOpen
2025-11-24Barclays$3579.1% upsideOpen
2025-11-04UBS$3894.5% upsideOpen
2025-11-04BarclaysPeter Lawson$2212.6% upsideOpen
2025-09-10Stifel Nicolaus$44125.2% upsideOpen
2025-07-15UBSDavid Dai$3579.1% upsideOpen
2025-07-10Goldman SachsCorinne Johnson$187.9% downsideOpen
2024-11-13ScotiabankGeorge Farmer$187.9% downsideOpen
2024-10-24UBSDavid Dai$3789.4% upsideOpen
2024-08-15CitigroupYigal Nochomovitz$3474% upsideOpen
2024-08-15Bank of America SecuritiesJason Zemansky$3158.6% upsideOpen
2024-08-15BarclaysPeter Lawson$3368.9% upsideOpen
2024-07-30Bank of America SecuritiesJason Zemansky$3053.5% upsideOpen
2024-06-28JefferiesKelly Shi$3789.4% upsideOpen
2024-05-09Stifel NicolausBradley Canino$40104.7% upsideOpen
2023-01-03J.P. Morgan$41109.8% upsideOpen
2022-12-12Goldman Sachs$3999.6% upsideOpen
2022-12-12H.C. Wainwright$3368.9% upsideOpen

Syndax Pharmaceuticals (SNDX) FAQ

The latest target price for SNDX is $38. Investors often review this figure alongside Syndax Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Syndax Pharmaceuticals trades near $19.54 while the consensus target sits at $38 (91.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting SNDX's target price ($38), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Syndax Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.